期刊文献+

益气解毒活络方对早期糖尿病肾病大鼠TGF-β/Smad信号通路的影响 被引量:4

Effect of Yiqi Jiedu Huoluo Formula on TGF-β / Smad Pathways in Rats with Early Diabetic Nephropathy
原文传递
导出
摘要 目的:研究益气解毒活络方(YQJDHL)对早期糖尿病肾病(DN)大鼠的治疗作用及对转化生长因子-β(TGF-β)/信号转导蛋白(Smad)信号通路的影响。方法:SPF级健康雄性SD大鼠72只,尾静脉注射链脲佐菌素(STZ)制造糖尿病(DM)模型,再根据大鼠血糖值高低对各治疗组进行随机分组,分别为模型组,YQJDHL预防组(2.4 g·kg-1·d-1),YQJDHL低、高剂量治疗组(2.4,7.2 g·kg^(-1)·d^(-1)),阳性药组(盐酸贝那普利,10 mg·kg^(-1)·d^(-1)),另设正常组,每组12只,YQJDHL预防组在成DM模型后立即给予灌服YQJDHL复方;YQJDHL低、高剂量组及西药组均在成DM模型2周后即成DN模型后灌服YQJDHL复方。在灌服YQJDHL 4周末收集大鼠24 h尿液待测尿微量白蛋白,腹主动脉穿刺取血测定大鼠血糖,留取肾组织标本,苏木素-伊红(HE)染色观察肾组织病理学的变化,逆转录-聚合酶链式反应(RT-PCR)法及蛋白质免疫印迹(Western blot)法观察YQJDHL对早期DN大鼠肾组织转化生长因子-β1(TGF-β1),Smad3,Smad7 mRNA及蛋白表达的影响。结果:与正常组比较,模型组大鼠血糖及尿微量白蛋白均明显升高,TGF-β1及Smad3表达明显升高,Smad7表达明显降低(P<0.01),病理学观察显示肾组织病变较明显;YQJDHL治疗组及预防组均能降低大鼠血糖及尿微量白蛋白,降低大鼠肾组织TGF-β1及Smad3表达,升高Smad7表达(P<0.05,P<0.01),肾组织病变明显改善。结论:YQJDHL能够预防和治疗DN,其作用机制可能与TGF-β/Samd信号通路有关。 Objective: To investigate the treatment effect of Yiqi Jiedu Huoluo formula( YQJDHL) in rats with early diabetic nephropathy( DN) and observe its effect on transforining growth factor-β( TGF-β) / Smad pathways. Method: Totally 72 SPF healthy male SD rats were used to establish diabetes mellitus( DM) models by tail injection of streptozotocin( STZ). Then according to the blood sugar levels,the rats were randomly divided into model group,YQJDHL prevention group( 2. 4 g·kg^-1·^-1),YQJDHL low dose group and high dose group( 2. 4,7. 2 g·kg^-1·^-1),positive drug group( benazepril hydrochloride,10 mg·kg^-1·^-1),another normal group was also set up,n = 12 in each group. In the YQJDHL preventive group,YQJDHL compound formula was immediately given after DM models were made. While in YQJDHL high and low dose groups and positive drug group,the medicine was given two weeks after the DM models were made,that was immediately after DN models were made. Four weeks after intragastrical administration of YQJDHL formula,24 h urine of rats was collected to determine the urine trace albumin, and the blood was taken by abdominal aorta puncture to determine blood glucose in rats; renal tissue samples were collected to observe the renal pathological changes by htoxylin-eosin( HE) staining method; the effects of YQJDHL TGF-β1,Smad3 /7 mRNA and protein expression levels in the kidney tissues of early DN rats were observed by reverse transcription-polymerase chain reaction( RT-PCR) and Western blot assay. Result: As compared with the normal group,the blood glucose and urine trace albumin were significantly increased in rats of model group; TGF-β1and Smad3 expression levels were significantly increased;Smad7 expression level was significantly reduced( P〈0. 01); and the renal pathological changes were obvious in pathological observation. QJDHL treatment groups and preventive group could reduce the blood glucose and urine trace albumin in rats, reduce TGF-β1and Smad3 expression levels in kidney tissues, and increase Smad7expression( P〈0. 05, P〈0. 01); in addition, renal pathological changes were significantly improved.Conclusion: The results showed that the YQJDHL formula had the treatment and prevention effect for the DN,and its mechanism of action may be associated with TGF-β / Smad signaling pathways.
作者 付晓 李敬林
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2016年第11期111-116,共6页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家自然科学基金面上基金项目(30973778) 辽宁省自然科学基金项目(2013022014)
关键词 益气解毒活络方 糖尿病肾病 转化生长因子-Β1 信号转导信号 Yiqi Jiedu Huoluo formula diabetic nephropathy transforming growth factor-β1 Smad
  • 相关文献

参考文献10

  • 1路在英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:770,775-776.
  • 2Cui X M,Shuler C F. The TGF-beta type 11I receptor is localized to the medical edge epithelium during palatal fuion[J]. Int J Dev Biol,2000,44(4) :397-402.
  • 3McGowan T A,Dunn S R,Falkner B,et al. Stimulation of urinary TGF-beta and isoprostanes in response to hyperglycemia in humans [ J ]. Clin J Am Soc Nephrol, 2006,1 (2) :263-268.
  • 4Wolf G,Chen S,Ziyadeh F N. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy [ J ]. Diabetes, 2005,54 ( 6 ) : 1626-1634.
  • 5Javelaud D,Mauvie A. Transforming growth factor-betas: Smad signaling and roles in physiopathology [ J]. Pathol Bio, 2004,52 ( 4 ) : 50-54.
  • 6付晓.中西医结合治疗早期糖尿病肾病疗效观察[J].辽宁中医药大学学报,2007,9(2):112-113. 被引量:2
  • 7邹新蓉,王长江,王小琴.威灵仙提取物对糖尿病肾病大鼠的作用[J].中国实验方剂学杂志,2015,21(16):152-156. 被引量:9
  • 8Weigert C, Brodbeck K, Klopfer K, et al. Angiotensin !1 inducse human TGF-beta 1 promoter activation:similarity to hyperglycaemia [ J ]. Diabetogia, 2002, 45 ( 6 ) : 890 -898.
  • 9Kuratomi G, Komuro A, Goto K, et al. NEDD4-2 ( neural precursor cell expressed, developmentally down-regulated negatively regulates TGF-b (transforming growth factor-b) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-b type 1 receptor[ J]. Biochem J,2005, 386(3) :461-470.
  • 10张金海,黄云剑,蔡文琴.Smad2,3,4,7蛋白在大鼠56肾切除肾衰模型中的定位和表达变化[J].第三军医大学学报,2004,26(13):1141-1144. 被引量:12

二级参考文献30

  • 1吕仁和,张洁荣,高彦彬.消渴病(糖尿病)中医分期辨证与疗效评定标准[J].中国医药学报,1993,8(3):54-56. 被引量:453
  • 2林凤平,任开明,宋恩峰,胡家才,吴凡.威灵仙对尿酸性肾病大鼠肾小管间质病变的保护作用[J].实用医学杂志,2006,22(1):18-20. 被引量:21
  • 3林凤平,任开明,宋恩峰,胡家才,吴凡.威灵仙对尿酸性肾病大鼠的实验研究[J].中成药,2006,28(6):842-845. 被引量:99
  • 4[1]Derynck R, Zhang Y E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling[J]. Nature, 2003, 425(6958): 577 - 584.
  • 5[2]Yu H T. Progression of chronic renal failure[J]. Arch Intern Med, 2003,163(12): 1417-29.
  • 6[3]Vindevoghel L, Lechleider R J, Kon a, et al. SMAD3/4-dependent reanscriptional activation of the human type Ⅶ collagen gene(COL7A1) promoter by transforming growth factor beta[J]. Proc Natl Acad Sci U S A, 1998,95(25): 14769 - 14774.
  • 7[4]Dennier S, Itoh S, Vinien D, et al. Direct binding of Smad3 and Smad4 to critical TGFβinducible elements in the promoter of human plasminogen activator inhibitor-type1 gene[J]. EMBO J, 1998, 17(11): 3091-3100.
  • 8[5]Ellis L R, Warner D R, Greene R M, et al. Interaction of Smads with collagen types Ⅰ , Ⅲ, and V [ J]. Biochem Biophys Res Commun, 2003,310(4): 1117- 1123.
  • 9[6]Kanamaru Y, Nakao A, Tanaka Y, et al . Involvement of p300 in TGFbeta/Smad-pathway-mediated alpha2 (I) collagen expression in mouse mesangial cells[J]. Nephron Exp Nephrol, 2003, 95(1): e36-42.
  • 10[7]Isono M, Chen S, Hong S W, et al. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells[J]. Biochem Biophys Res Commun, 2002, 296(5): 1356- 1365.

共引文献20

同被引文献81

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部